Middle East and Africa Smoking Cessation And
Nicotine De-Addiction Industry Information, by Treatment (pharmacological,
therapies and others), by Product Type (drugs, inhalers, patches, sprays &
gums and others), Distribution Channels (pharmacies, online, de-addiction
centers) - Forecast to 2022
The Smoking Cessation And Nicotine De-Addiction
Industry in the Middle East and Africa is growing rapidly.
Factors such as the increasing desire of addicts to quit smoking and an
increasing number of ‘quit smoking’ movements led by the social and health
organizations support the growth of the market. Moreover, the increasing or
prohibitive costs of tobacco products due to high taxes leveraged and social
stigma imposed on tobacco users escalates the market on the larger and widened
platform.
Acknowledging the kind of gains the market
perceives currently, Market Research Future (MRFR) in its recently published
study report asserts that the Middle East and Africa Smoking Cessation And
Nicotine De-Addiction Industry will reach over USD 2108.38 MN, by 2022
registering a significant CAGR of 12.5%. from 2018 to 2022.
In the Middle East, especially in Gulf Cooperation
Council (GCC) countries, women and young people have picked up the habit of
smoking hookah, a traditional smoking tool known as shishah or nargilah in the
Arab world which have given the industry inroads to the two demographic groups
that traditionally consume less tobacco.
On the other hand, government initiatives are
becoming super successful means to quell the urge among smokers in the MEA
region. Through these initiatives, the governments have been taking bold steps
towards reducing causalities due to tobacco addiction. The World Health
Organization (WHO) has also joined forces with Muslim fundamentalists who
condemn smoking as evil. These movements
have gone further by encouraging religious leaders previously not active
anti-smokers to take up the cause.
Resultantly, the Tobacco industry has prudently
stepped back from religious arguments, and it seems that its hold over Arab
smokers is cracking, finally. However, the industry still retains much of its
ability to hawk products in Middle Eastern and North African markets.
The inclusion of Nicotine replacement therapy (NRT)
in the mainstream de-addiction movement is a progressive move which is having a
far-reaching impact on the physical and economic health of these regions.
Although NRT (both as gum and a patch format) has been enlisted by the WHO as
an Essential Medicine to quit smoking, yet NRT had not been adopted as the
first form of treatment.
The Middle East and Africa Smoking Cessation & Nicotine
De-Addiction Market - Segments
For ease of understanding, the market has been segmented into four key
dynamics: -
By
Treatment : Pharmacological and
Therapies among others.
By
Product Type : Drugs,
Inhalers, Patches, and Sprays & Gums among others.
By
Distribution Channel : Pharmacies,
Online, and De-addiction Centers among others.
By Region :
GCC countries and African countries
Browse Complete Report : https://www.marketresearchfuture.com/reports/mea-smoking-cessation-nicotine-de-addiction-market-2737
MEA Smoking Cessation And Nicotine De-Addiction Industry
- Regional Analysis
Continuing
with its dominance, the UAE market for smoking cessation and nicotine
de-addiction is estimated to surge, witnessing high consumption of de-addiction
products. UAE is expected to create a more significant revenue pocket in the
Middle East and Africa market.
The
Middle East is a big market for tobacco and its products and accounts for
significantly higher smoking rates in the world, but there is growing interest
in quitting and an expanding market for de-addiction programs. Middle Eastern
and North African governments seem to be vulnerable to the influence of
Tobacco.
However,
they are proving that this influence they can wield to jarring. They leverage
their positions to take up various movements that can help elite to become
community pillars to advocate for their interests. Resultant, smoking cessation
and nicotine de-addiction products have consistently defended its ample
footprint in the Middle Eastern region.
Moreover,
the recent decision of the Emirates Authority for Standardization and Metrology
(ESMA) to allow the sale of vaping devices is expected to help de-addiction.
The major reason behind the move is the growing popularity of the unregulated
products available online.
Additional
factors such as high disposal income, the presence of plentiful smokers,
influence the growth of the regional market, positively. Also, factors such as
the continual R&D efforts transpired in the field to bring novelties in the
de-addiction products and high per capita income support the growth of the regional
market.
The
Egypt smoking cessation and nicotine de-addiction products market closely
follows the UAE market, accounting for the second-largest market in the MEA
region. Whereas, Algeria and South
Africa followed by Ethiopia are emerging as the fastest growing markets in
Africa. However, the large unmet medical needs make the rest of Africa market
the most prominent one.
MEA Smoking Cessation & Nicotine De-Addiction Market –
Competitive Analysis
The Smoking
Cessation And Nicotine De-Addiction Industry in the Middle East and Africa
appears to be highly competitive with the presence of well-established players
having regional as well as global presence. These market players compete
against each other on the basis of quality, price, reputation, service, and
distribution. Mergers & acquisitions, brand reinforcement, and innovations
remain the key strategies adopted by the leading players of the market. The
market will witness fierce competition due to the expected product &
service extensions and product innovations.
Major Players:
Key
players leading the MEA Smoking Cessation And Nicotine De-Addiction Industry
include VMR Products LLC, Pfizer Inc, Johnson & Johnson, Cipla Inc.,
Novartis International AG, GlaxoSmithKline plc., Nicotek LLC., and Lorillard,
Inc. among others.
Industry Advancements/Related
News
March 08, 2019 – The Government of India (GoI)
introduced Nirmal, a nicotine replacement gum under its Pradhan Mantri Bhartiya
Janaaushadhi Pariyojana (PMBJP), strengthening its commitment to fight tobacco
addiction in the country.
Launched
on the occasion of Janaushadh Diwas (Generic Medicine day), promotion of Nirmal
is a bold step by the GOI to achieve the objectives as per India’s National
Health Policy 2017. Starting from March 08th, 2019, Nirmal would be available
across the country in the Pradhan Mantri Janaushadhi Kendras (PM Generic
Medicine Centers).
No comments:
Post a Comment